2008 NSTI Nanotechnology Conference and Trade Show - Nanotech 2008 - 11th Annual
Technical Conferences
Merck Corporate Needs
NanoInk Symposium
Nano Electronics & Photonics
Nano Fabrication
Sensors & Systems
Micro & Nano Fluidics
MSM - Modeling Microsystems
WCM - Compact Modeling
Nanostructured Materials & Devices
Soft Nanotechnologies & Applications
Nanoparticles in Soft Materials - Colloidal Systems
Polymer Nanotechnology
Carbon Nano Structures & Devices
Nano Particles & Applications
Nanostructured Surfaces and Interfaces
Nanoscale Characterization
Energy Technologies & Applications
Nanotech in Health, Environment & Society
ICCN - Nanoscale Modeling
Bio Nano Materials & Tissues
Bio Sensors & Diagnostics
Biomarkers & Nanoparticles
Cancer Diagnostics, Imaging & Treatment
Drug Delivery & Therapeutics
Nano Medicine
Nanotech to Neurology
Phage Nanobiotechnology
Clean Technology 2008
Industrial Impact Workshop
Confirmed Speakers
Program Committee

Partnering Events:

TechConnect Summit
Clean Technology 2008

Nano Medicine

Symposium Sponsor


Symposium Sessions


Monday June 2

10:30 Nanotech for Neurology
1:30 Nanoparticles: Nanoparticles for Biology and Medicine
1:30 Cancer Diagnosis, Imaging and Treatment - 1
 Nanotech for Neurology
 Nano Medicine

Tuesday June 3

8:30 Cancer Diagnosis, Imaging and Treatment - 2
 Merck Innovation Symposium: siRNA Delivery
 Phage Nanobiotechnology
3:30 Merck Innovation Symposium: siRNA Delivery

Wednesday June 4

8:30 Nanotechnology for Cancer Prevention, Diagnosis and Treatment
10:30 Nanotechnology for Cancer Prevention, Diagnosis and Treatment
10:30 Phage Nanobiotechnology
1:30 Nanotechnology for Cancer Prevention, Diagnosis and Treatment
1:30 Phage Nanobiotechnology
3:30 Nanotechnology for Cancer Prevention, Diagnosis and Treatment
4:00 Phage Nanobiotechnology
 Cancer Diagnostics, Imaging & Treatment

Thursday June 5

8:30 Biomarkers and Nanoparticles
10:30 Lab on Chip - 1
10:30 Drug and Gene Delivery Systems
1:30 Lab on Chip - 2

Symposium Program


Monday June 2

Back to Top
10:30 Nanotech for NeurologyRoom 208
 Session chair: Sarah Tao, Draper Laboratroy, US
10:30 Quantum dot (Qdot) labeling of gene expression analysis and single molecule imaging in neurons
A. Jeromin, Z. Riley, E. Byrnes, S. Parry, S. Smith, N. Dee, A. Jones, Allen Institute for Brain Science, US
11:00 Myelin-mimetic lipid multilayers
S. Iyer, A. Dattelbaum, J. Majewski, A. Shreve, Los Alamos National Laboratory, US
11:20 High Resolution Labeling of Proteins Implicated in Central Nervous System Injury and Disease using Quantum Dot Nanocrystals
S. Pathak, G. Silva, University of California, San Diego, US
11:40 Novel nanostructures for brain stroke repair:towards the development of nanoscaled bypass
M. Leon, E. Ferrer, L. Gonzalez, R. Irizarry, M. Castro, Chemical Imaging Center, US
12:00 Vertically Arranged Gold Nanowires: An Interface for Live Neuronal Recordings
S. Saha, D.M. O’Malley, L. Menon, Northeastern University, US
12:20 Nanostructured Hybrid Organic Biomaterials for Neural Interfaces
M.R. Abidian, D.C. Martin, D.R. Kipke, University of Michigan, US
Back to Top
1:30 Nanoparticles: Nanoparticles for Biology and MedicineRoom 203
 Session chair: Srinivas Iyer, LANL, US
1:30 Effect of Medical Device Substrate Material on Nanoparticulate Silver Efficacy
B.J. Dair, K.M. Kennedy, R.S. Casas, FDA, US
1:50 The Use of Gold-Citrate Nanoparticles and Curcumin Nanomedicine to Target Cancer at a Single Cell Level
A. Moten, Harvard University, US
2:10 Combinatorial optimization, a paradigm shift in targeted particle drug delivery development
J. Wright, BIND, US
2:30 Nanomaterial: A realistic business case for Pharma
T.H. Keller, GlaxoSmithKline, UK
2:50 Towards nanosized particles in pharmaceutical industry
N.R. Bieri, U. Meier, E. Goncalves, D. Zimmermann, M. Juhnke, R. Thakur, Novartis Pharma AG, CH
Back to Top
1:30 Cancer Diagnosis, Imaging and Treatment - 1Room 208
 Session chair: Linda Molnar, National Institutes of Health, US
1:30 Nanomedicine: Engineering of a Tri-Imageable Nanoparticle for Cancer Diagnostics
A. Bumb, PJ. Dobson, L. Fugger, P. Choyke, MW. Brechbiel, National Cancer Institute/University of Oxford, US
1:50 Gold Nano-Probes as Targeted CT Contrast Agents for In-vivo cancer Imaging
R. Popovtzer, A. Agrawal, M. Shlomi, A. Popovtzer, J. Balter, T.E. Carey, R. Kopelman, University of Michigan, US
2:10 Electrokinetic Separation and Detection of DNA Nanoparticles and Cancer BioMarkers
M.J. Heller, R. Krishnan, B. Sullivan, R. Mifflin, S. Esener, University of California, San Diego, US
2:30 Development of EGFR-based Glioblastoma Targeting Imaging Agents
U. Trojahn, Z. Zhang, U. Iqbal, M. Jaramillo, J. Baardsnes, A. Abedelnasser, J. Zhang, R. MacKenzie, D. Stanimirovic, T. Veres, B. Tomanek, M. O’Connor-McCourt, McGill University, CA
Back to Top
Nanotech for NeurologyExhibit Hall C
- Evaluation For The Current Management of Pompe Disease
U.A. Khan, University of Manchester, UK
- Advances in Automated 3D cortex image data acquisition
B. Lich, J. Greiser, P. Faber, G. Knott, FEI Company, NL
- Permeability of An In Vitro Model of Blood Brain Barrier (BBB)
R. Amin, COMSATS Institute of Information Technology, PK
- CNT and Organic FETs Based Two-Way Transducing of the Neurosignals
R. Sklyar, Independent researcher, UA
Back to Top
Nano MedicineExhibit Hall C
- Temperature Sensitive Liposomes for Local Drug delivery Using Focused Ultrasound
M. Larabi, M. Mackanos, R. Shinde, C. Contag, S. Guccione, Stanford University, US
- Low molecular weight heparin-vectorized _-cyclodextrin nanostructures
E. Vismara, D. Pizzolato, S. Bertini, G. Torri, A. Valerio, Politecnico, IT
- The different biological activity between the colloidal silver nanoparticle and the plasma silver nanoparticle in various cell types
S-G Kim, Hallym University, KR
- Magnetically associated carbon nanotubes with mammalian cells: flow cytometry characterization and applications
D. Cai, D. Blair, F.J. Dufort, M.R. Gumina, Z. Huang, G. Hong, K. Kempa, Z.F. Ren, T.C. Chiles, Boston College, US
- Mesoporous Silica Particles Induce Size Dependent Effects on Human Dendritic Cells
H. Vallhov, S. Gabrielsson, M. Strømme, A. Scheynius, A.E. Garcia-Bennett, Karolinska Institutet, SE
- Nanoparticle-enhanced Magnetic Field Induces Apoptosis in Nematode
G.S. Huang, L.K. Yeh, Y.C. Chen, National Chiao Tung University, TW
- Potential anti-inflammatory properties of biologically-synthesized nanoparticles of gold or silver
K.P. Vercruysse, S.L. Harper, D.M. Ivory, M.M. Whalen, K.S. Saili, R.L. Tanguay, Tennessee State University, US
- NanoBio-Tools for Selective Activation of Toll-like receptors (TLRs)
M.I. Shukoor, F. Natalio, P. Langguth, W. Schreiber, H.C. Schröder, W.E.G. Müller, W. Tremel, Johannes-Gutenberg University, DE
- Improved Tissue Distribution, Renal Clearance and Toxicity Profile of Functionalised Carbon Nanotubes
L. Lacerda, M. Prato, A. Bianco, K. Kostarelos, The School of Pharmacy, University of London, UK
- In-vitro evaluation of carbon nanotube mediated gene delivery for colon cancer
A. Kulamarva, M. Malhotra, J. Bhathena, S. Sebak, S. Prakash, McGill University, CA
- Multifunctional Polymeric Nanosystems for EGFR Gene Silencing
S. Pai, M. Amiji, Northeastern University, US
- Carbon Nanopipes dispersions in aqueous solutions and effects on cell viability
M. Whitby, J. Lin, N. Quirke, M. Thanou, Imperial College London, UK
- Novel Resorbable Drug-Carrying Nano-Scaffolds for Treating Bone Diseases at Targeted Sites
H. Liu, T.J. Webster, Brown University, US
- Engineering and Evaluation of Carrier-Free Methotrexate Nanospheres
E. Hassan, S. Gumudavelli, Pharmaceutics International, US
- Removing Active Species by Fullerenol in vitro and in vivo
J-J. Yin, F. Lao, W-G. Wamer, Y. Zhao, X. Gao, P-C Wang, C. Chen, X-J. Liang, National Center for Nanoscience and Technology of China, CN
- Monofunctional Gold Nanoparticles-Synthesis and Applications in Nanomedicine
Q. Dai, X. Liu, J. Zou, Q. Huo, Nanoscience Technology Center, University of Central Florida, US
- Non-Condensing Calcium Alginate Microspheres for Macrophage-Selective Gene Delivery and Transfection
S. Jain, M. Amiji, Northeastern University, US
- The therapeutic effects of silver nanoparticle on the inflammatory disease of the temporomandibular joint
S.G. Kim, A.S. Kim, A.R. Lee, Hallym Univerisity, KR
- Dendrimeric Nanocontainers as Anti-Angiogenic Therapeutics
K.T. AL-Jamal, S. Akerman, J.E. Podesta, W.T. Al-Jamal, J.A. Turton, C. Kanthou, N. Vargesson, G.M. Tozer, K. Kostarelos, Nanomedicine Lab, UK
- Composite Nanodevices in Imaging and Treatment of Cancer
L.P. Balogh, W. Lesniak, M.T. Ould Ely, M. O’Donnell, C. Tse, M. Zohdy, J.Y. Ye, M.T. Kariapper, M.K. Khan, Roswell Park Cancer Institute, US
- Upconverting nanoparticles for in vitro and in vivo cellular imaging
D.K. Chatterjee, Y. Zhang, National University of Singapore, SG
- Synthesis and Surface Modification of Gold Nanoparticles for Biomolecular Imaging and Detection Applications
Q. Dai, J. Coutts, X. Liu, L. Austin, Q. Huo, University of Central Florida, US
- Bulk Synthesis of Nanoparticles for Bioimaging and Targeted Delivery
J. Hu, C. Khemtong, H. Wang, J. Weingart, The University of Akron, US
- Emerging Trends of Nanotechnology towards Picotechnology: Energy and molecules
R. Sharma, A. Sharma, C.J. Chen, Florida State University, US
- Use of Nanoparticles as Therapy for Respiratory Syncytial Virus Inhibition
K. Vig, S. Boyoglu, V. Rangari, L. Sun, A. Singh, S. Pillai, S.R. Singh, Alabama State University, US
- Inflammation and Cellular Toxicity Study of PAMAM Dendrimer Nanoparticles in Primary Isolated Human Lung Cells
M.K. Khan, M.S.T. Kariapper, V. Kasturirangan, W. Lesniak, M. Sharma, H. Baumann, L.P. Balogh, Translational Research Scientist, US
- In Vitro Toxicity Study of Gold and Tin Composite Nanodevices for use in Imaging and Radiotherapy
M.K. Khan, M.S.T. Kariapper, V. Kasturirangan, B. Nair, W. Lesniak, L.P. Balogh, Roswell Park Cancer Institute, US
- Evaluation of Nanoencapsulated DNA Vaccine for RSV
S. Boyoglu, K. Vig, V. Rangari, S. Pillai, V. Dennis, S.R. Singh, Alabama State University, US

Tuesday June 3

Back to Top
8:30 Cancer Diagnosis, Imaging and Treatment - 2Room 208
 Session chair: J. Manuel Perez, University of Central Florida, US
8:30 Nanotechnology: A Key Enabler of Personalized Medicine
L. Molnar, National Institutes of Health, US
9:00 Strategies for enhanced brain tumor accumulation of magnetic nanoparticles for potential drug delivery
B. Chertok, A.E. David, V.C. Yang, University of Michigan, US
9:20 5-aminolevulinic Acid Conjugated Gold Nanoparticles for Cancer Treatment
M.K. Khaing Oo, X. Yang, H. Wang, H. Du, Stevens Institute of Technology, US
9:40 Multiwalled Carbon Nanotube-Doxorubicin Supramolecular Complexes for Cancer Therapeutics
H. Ali-Boucetta, K.T. Al-Jamal, K. Kostarelos, The School of Pharmacy, University of London, UK
Back to Top
Merck Innovation Symposium: siRNA DeliveryExhibit Hall C
- Labile Catalytic Packaging and Delivering of Short Interference RNA to Cancer Cells: Control of Gold Nanoparticles “out” of RNA Complexes
A.M. Chen, O. Taratula, D. Wei, T. Minko, H. He, Rutgers, The State of New Jersey, US
- In vitro transfection efficiency of chitosan nanoparticles for gene delivery
M. Malhotra, A. Kulamarva, S. Sebak, J. Bhathena, S. Prakash, McGill University, CA
- Toward in vivo Targeting Delivery of siRNA for Efficient Cancer Therapy
O. Taratula, P. Kirkpatrick, R. Salva, I. Pandya, T. Minko, H. He, Rutgers-Newark University, US
- SiRNA for Therapeutic Immuno-modulation: Simultaneous Delivery of Cytokine-targeted SiRNA and DNA Antigens to Dendritic Cells using Polymer Microcarriers
A. Singh, H. Nie, B. Ghosn, K. Roy, The University of Texas at Austin, US
- Multilayered ABCD Nanoparticles for siRNA delivery
M. Thanou, A. Miller, Imperial College London, UK
- Delivery systems for enhanced siRNA delivery
A-L. Bolcato-Bellemin, M-E. Bonnet, J-P. Behr, P. Erbacher, Polyplus-transfection, FR
Back to Top
Phage NanobiotechnologyExhibit Hall C
- Phage microarray
K.A. Vaglenov, S.N. Ustinov, G.A. Kuzmicheva, V.A. Petrenko, Auburn University, US
- Modulating affinity of landscape phage nanoparticles by mutagenesis of the major coat protein
G.A. Kuzmicheva, A.M. Eroshkin, V.A. Potemkin, V.A. Petrenko, Auburn University, US
- Landscape phage libraries as a source of bioselective nanomaterials
G.A. Kuzmicheva, I.B. Sorokulova, P.K. Jayanna, V.A. Petrenko, Auburn University, US
- Directed Evolution of Bone Associated Protein Through Phage Display
S.-W. Lee, University of California, Berkeley, US
- Engineering of bacteriophages displaying affinity tags on its head for biosensor applications
M. Tolba, L.Y. Brovko and M.W. Griffiths, University of Guelph, CA
- Engineering hybrid nanostructures with phage particles
L. Makowski, L. Chen, Argonne National Laboratory, US
- Landscape phage probes for PC3 prostate carcinoma cells
P.K. Jayanna, P. Deinnocentes, R.C. Bird, V.A. Petrenko, Auburn University, US
- Landscape Phage Probes for Breast Cancer Cells
O.A. Fagbohun, D. Bedi, P.K. Jayanna, P.A. Deinnocentes, R.C. Bird, V.A. Petrenko, Auburn University, US
- Unspecific uptake of M13-type bacteriophage into human endothelial cell lines.
O.A. Mandrup, P. Kristensen, University of Aarhus, DK
- Phage engineering for neural tissue regeneration
A.M. Merzlyak, S.W. Lee, UC Berkeley, US
- Genetically engineered M13 bacteriophages as standalone tethers for probing single-molecule protein-DNA interactions
A.S. Khalil, J.Y. Mao, D. Ghosh, M.J. Lang, A.M. Belcher, Massachusetts Institute of Technology, US
- High speed Atomic Force Microscopy for imaging Cell-Virus interactions
G.E. Fantner, D.S. Gray, I.W. Rangelow, A.M. Belcher, Massachusetts Institute of Technology, US
- Biotemplated synthesis of materials for photo-oxidation of water
A. Magyar, S. Cui, Y-S Nam, V. Dini, A.M. Belcher, Massachusetts Institute of Technology, US
- Evolutionary selection of bone mineral hydroxyapatite binding peptide using landscape phage library
S. Modali, G. Abbineni, P. Jayanna, V. Petrenko, C. Mao, University of Oklahoma, US
Back to Top
3:30 Merck Innovation Symposium: siRNA DeliveryRoom 208
3:30 Introduction: siRNA Delivery
A. Sachs, Merck, US
3:40 Development of a new RNAi therapeutics platform
J. Kamens, W. Salomon, H. Baigude, J. McCarroll, C.-S. Yang, P. Swain, T. Rana, T. Woolf, D. Samarsky, P. Pavco, RXi Pharmaceutical, US
4:00 Amphoteric liposomes are a platform for multi-organ delivery of oligonucleotides
C. Reinsch, U. Rauchhaus, S. Panzner, novosom AG, DE
4:20 Oral Delivery of Map4K4 siRNA to Macrophages Inhibits TNF alpha Production and Protects against a LPS-Galactosamine Challenge in Mice
M. Aouadi, G. Tesz, E. Soto, M. Wang, S. Nicoloro, G. Ostroff, M. Czech, University of Massachusetts Medical School, US
4:40 Systemic Delivery of Targeted, siRNA-Containing Nanoparticles for the Treatment of Solid Tumors: Concept to Clinic
J.D. Heidel, J.Y-C. Liu, R.K. Zeidan, Y. Liang, S. Rele, M.E. Davis, Calando Pharmaceuticals, US
5:00 Targeting and Delivery of siRNA using Nanoparticles Fabricated via the PRINT Process
D.A. Canelas, X. Gao, S. Tian, P.A. Ropp, J.M. DeSimone, University of North Carolina at Chapel Hill, US
5:20 Long-Circulating Micelle-like DNA-encapsulating Nanoparticles for Systemic Gene Delivery
Y.T. Ko, W.C.A. Kale, V.P. Torchilin, Northeastern University, US
5:40 Efficient siRNA Delivery by Secondary and Tertiary Amine Modified Polysaccharides
B. Ghosn, A. Singh, K. Roy, The University of Texas at Austin, US

Wednesday June 4

Back to Top
8:30 Nanotechnology for Cancer Prevention, Diagnosis and TreatmentRoom 210
 Session chair: Vladimir Torchilin, Northeastern University, US
8:30 Cancer Gene Therapy Using Nanoparticle Vectors
J.A. Roth, Anderson Cancer Center, US
9:15 Folate-Targeted Nanoparticle Therapies for Cancer
P.S. Low, Purdue University and Endocyte Pharmaceuticals, US
Back to Top
10:30 Nanotechnology for Cancer Prevention, Diagnosis and TreatmentRoom 210
 Session chair: Vladimir Torchilin, Northeastern University, US
10:30 Clinical Translation of Nanotechnology for Cancer: The NCI Alliance’s Perspective
P. Grodzinski, NCI/NIH, US
11:00 Nanotechnology Applied to Clinical Biomarker Medicine
L. Liotta, George Mason University, US
11:30 Integrated Nanoplatforms for Cancer Detection
S.R. Manalis, Massachusetts Institute of Technology, US
Back to Top
10:30 Phage NanobiotechnologyRoom 209
 Session chair: Valery Petrenko, Auburn University
10:30 Evolution of Phage Display Towards Nanobiotechnology
V. Petrenko, Auburn University, US
10:50 Structure of Filamentous Phage Particles and Their Components
S.J. Opella, University of California, San Diego, US
11:10 Phage Nanoparticles: Replication and Assembly
G.P. Smith, University of Missouri, US
11:30 Phage-Based Patient-Specific Navigation Systems
S.L. Deutscher, University of Missouri, US
11:50 Imaging with Phage Probes
K.A. Kelly, Harvard Medical School/MGH, US
Back to Top
1:30 Nanotechnology for Cancer Prevention, Diagnosis and TreatmentRoom 210
 Session chair: Vladimir Torchilin, Northeastern University, US
1:30 Molecular Imaging in Cancer
A. Moore, MGH/Harvard Medical School, US
2:00 Magnetic Nanoparticles for Thermal Therapy
J. Hoopes, Dartmouth Medical Center, Hanover, NH, US
2:30 Nanocarriers for Tumor-Targeted Drug Delivery
T. Minko, Rutgers, US
Back to Top
1:30 Phage NanobiotechnologyRoom 209
 Session chair: Angela M. Belcher, Massachusetts Institute of Technology, US
1:30 Phage-derived Vehicles for Gene and Drug Delivery
V. Petrenko, Auburn University, US
1:50 Phage-Templated Synthesis of Inorganic Nanomaterials
A.M. Belcher, Massachusetts Institute of Technology, US
2:10 Site-Directed Chemical Modification of Phage Particles
C.J. Noren, New England Biolabs, US
2:30 Phage-based Biorecognition Interfaces in Biosensors
B.A. Chin, Auburn University, US
2:50 Human tumor-specific phage nanoparticles
D. Krag, The University of Vermont, US
Back to Top
3:30 Nanotechnology for Cancer Prevention, Diagnosis and TreatmentRoom 210
 Session chair: Vladimir Torchilin, Northeastern University, US
3:30 Nanocell Delivery System for Combination Cancer Therapy
M.N. Milton, Tempo Pharmaceuticals, US
4:00 Multifunctional Nanocarriers for Cancer Therapy
V. Torchilin, Northeastern University, US
Back to Top
4:00 Phage NanobiotechnologyRoom 209
 Session chair: Valery Petrenko, Auburn University
4:00 Combinatorial Phage Nanobiotechnology
L. Makowski, Argonne National Laboratory, US
4:20 Targeting Nanoparticle Probes to Differentiating Stem Cells
J. Cabral-Teixeira, K. Benjamin, L. Zhang, J. Maurer, M. Tsuda, Y.S. Chao, N. Prigozhina, J. Price, E. Snyder, M. Mercola, E. Ruoslahti, M.D. West, D. Larocca, Advanced Cell Technology, US
4:40 Phage Probes for Cancer Diagnostic and Treatment
T.I. Samoylova, N.E. Morrison, N.R. Cox, Auburn University, US
5:00 Pharmacokinetic Optimization of Phage Particles for Gene-Delivery
A. Baird, D. Larocca, University of California San Diego Medical Center, US
5:20 Targeted Drug-carrying Filamentous Phage Nanomedicines
I. Yacoby, H. Bar, L. Vax, I. Benhar, Tel Aviv University, IL
Back to Top
Cancer Diagnostics, Imaging & TreatmentRoom 302
- Genomics and Proteomics: Information-Theoretic Analysis in Frequency Domain
S.E. Lyshevski, F. Krueger, Rochester Institute of Technology, US
- Colorectal Cancer Cell Detection by Chitosan Nanoparticle Conjugated with Folic Acid
S-J Yang, J-W Chen, M-J Shieh, Institute of Biomedical Engineering, TW
- Chitosan Nanoparticle Combined with Ultrasound for Cervical Cancer Detection
K-C Tsai, M-J Shieh, S-J Yang, W-L Lin, W-S Chen, Institute of Biomedical Engineering, TW
- Lipid core near infrared imaging agent for in vivo whole body imaging
A. Papagiannaros, A. Kale, D. Chovatia, T. Levchenko, W. Hartner, D. Mongayt, V. Torchilin, Northeastern University, US
- Cancer Cell Diagnosis by Targeted Delivery of Nanodevices
I. Hajdu, E. Nagy, M. Bodnar, J.F. Hartmann, S. Damjanovich, J. Kollar, G. Vamosi, J. Borbely, University of Debrecen, HU
- Functionalized quantum dot-liposome hybrid nanoparticles for cancer
W.T. Al-Jamal, K.T. Al-Jamal, K. Kostarelos, Nanomedicine Laboratory, UK
- Developing superparamagnetic iron oxide nanoparticles as tumor-specific magnetic resonance imaging (MRI) contrast agents
R.M. Sawant, E. Gultepe, D. Nagesha, S. Sridhar, V.P. Torchilin, Northeastern University, US
- Biochip-Based Test System for Cancer Diagnostics. Simultaneous Quantitation of Total and Free Forms of Prostate-Specific Antigen
T. Osipova, Z. Sokolova, T. Ryabykh, V. Karaseva, M. Modorsky, V. Matveev, A. Baryshnikov, N.N. Blokhin Cancer Research Center, RAMS, RU
- Novel Micellular Formulations of a Polyethylene Glycolated Pyropheophorbide-a-Peptide Conjugate for Photodiagnosis and Photodynamic Therapy
M.D. Savellano, Dartmouth College, US
- Newer Nanoparticles in Hyperthermia Treatment and Thermometry
R. Sharma, C.J. Chen, Florida State University, US
- Specific device for cells sampling
M.L. Cosnier, F. Martin, D. Ratel, F. Berger, P. Caillat, Commissariat à l’énergie atomique, FR
- New efficient nanostructural near-IR photosensitizer for photodynamic therapy of malignancies based on micellar dispersion of zinc octa-4,5-decylthio-3,6-chloro-phthalocyanine
I.G. Meerovich, G.A. Meerovich, E.A. Lukyanets, V.M. Negrimovsky, S.V. Barkanova, A.A. Zorin, L.V. Umnova, N.A. Oborotova, V.B. Loschenov, G.N. Vorozhtsov, A.Yu. Baryshnikov, N.N.Blokhin Russian Cancer Research Center of RAMS, RU
- Influence of liposome size on accumulation in tumor and therapeutic efficiency of liposomal near-IR photosensitizer for PDT based on aluminum hydroxide tetra-3-phenylthiophthalocyanine
G.A. Meerovich, I.G. Meerovich, V.G. Pevgov, E.A. Lukyanets, N.A. Oborotova, D.G. Gurevich, A.A. Zorin, V.M. Derkacheva, Z.S. Smirnova, V.B. Loschenov, G.N. Vorozhtsov, A.Yu. Baryshnikov, A.M. Prokhorov General Physics Institute of RAS, RU
- Mathematical Model of effect of drug delivery on blood flow in external magnetic field by Magnetic Nanoparticles
S. Mishra, V.K. Katiyar, V. Arora, Indian Institute of Technology Roorkee, IN
- Fabrication of magnetic Co-Ferrite-SiO2 nanoparticles using Hydroxyapatite (HAp) as templates for nanomedicine
W. Pon-on, Mahidol University, TH
- Multifunctional siRNA Delivery System for Cancer Therapy
O. Taratula, R. Salva, I. Pandya, A. Wang, T. Minko, H. He, Rutgers-Newark University, US
- Preparation and investigation of biological activity of thermosensitive liposomes loaded with doxorubicin
E.V. Tazina, A.V. Polozkova, O.L. Orlova, E.V. Ignatieva, V.V. Mescherikova, A. Wainson, S.P. Yarmonenko, N.A. Oborotova, N.N. Blokhin Russian Cancer Research Center of RAMS, RU
- Multi- Walled Carbon Nanotubes Increase the Efficiency of Hyperthermic Chemotherapy
N.H. Levi-Polyachenko, E. Merkel, B.T. Jones, W.D. Wagner, D.L. Carroll, J.H. Stewart IV, Wake Forest University Health Sciences, US
- Bacterial Drug Delivery Systems and nanoparticles
R. Sharma, Y. Haik, UNCG, US
- Immunomicelles for Delivery of Poorly Soluble Anticancer Drugs: Improved Solubilization and In Vitro Cytotoxicity
R.R. Sawant, V.P. Torchilin, Northeastern University, US
- Structural plasticity of transmembrane peptides allows generation of self-assembling uniform nanoparticles with innate biological activity
S.G. Tarasov, V. Gaponenko, O.M.Z. Howard, M. Dyba, S. Subramaniam, C.J. Michejda, N.I. Tarasova, National Cancer Institute at Frederick, US
- Pharmacokinetic study of PEGylated plasmon resonant gold nanoparticles in tumor-bearing mice
B.Ya. Kogan, N.V. Andronova, N.G. Khlebtsov, B.N. Khlebtsov, V.M. Rudoy, O.V. Dement’eva, E.M. Sedykh, L.N. Bannykh, FGUP “GNC “NIOPIK”, RU
- Upconverting nanoparticles for photodynamic therapy
D.K. Chatterjee, Y. Zhang, National University of Singapore, SG
- Spatio-temporal Tumor Model for Analysis and Mechanism of action of Intracellular Drug Accumulation
S. Mishra, V.K. Katiyar, V. Arora, Haridwar, IN

Thursday June 5

Back to Top
8:30 Biomarkers and NanoparticlesRoom 308
 Session chair: Srinivas Iyer, LANL, US
8:30 Multiplexed Proteolytic Enzyme Assay Based on Energy Transfer between Quantum Dots and Gold Nanoparticles
Y.H. Oh, Y.P. Kim, H.S. Kim, Korea Abvanced Institute of science and Technology, KR
8:50 2-Nitroimidazole as Potential Nanoprobe in Hypoxia Imaging by MRI/PET
R. Sharma, A. Sharma, University of North Carolina, US
9:10 Biomolecular activity switch: an application of metallic nanoparticle plasmon resonance
J. Alper, A. Wijaya, M. Crespo, L. DeFlores, A. Tokmakoff, K. Hamad-Schifferli, Massachusetts Institute of Technology, US
9:30 Functional Nanoparticles for Biomedical Applications
Y. Durant, E. de Muinck, Nanostructured Polymers Research Center, US
9:50 Multifunctional nanoparticle platforms for pathogen diagnostic applications
A.J. Kell, C. Paquet, B. Simard, National Research Council, CA
Back to Top
10:30 Lab on Chip - 1Room 313
 Session chair: Srinivas Iyer, LANL, US
10:30 MEMS based examination platform for a neuro-muscular communication in a co-culture system coupled to a multi-electrode-array
M. Fischer, M. Klett, U. Fernekorn, C. Augspurger, A. Schober, Technische Universität Ilmenau, DE
10:50 GRAVI-Chip: Automation of Microfluics Affinity Assay based on Magnetic Nanoparticle
J.S. Rossier, S. Baranek, P. Morier, F. Vulliet, C. Vollet, F. Reymond, DiagnoSwiss SA, CH
11:10 One-step White Blood Cell Separation from Whole Blood
J-M Park, B-C Kim, J-G Lee, Samsung Advanced Institute of Technology (SAIT), KR
11:30 Detection of Clinical Biomarkers using a novel parabolic microchip diagnostic platform
D. Hill, S. Hearty, L. Basabe-Desmonts, R. Blue, C. McAtamney, R. O’Kennedy, B. MacCraith, Dublin City University, IE
Back to Top
10:30 Drug and Gene Delivery SystemsRoom 311
 Session chair: Steve Xanthoudakis, Merck, US
10:30 Cell-mediated, heat-based therapy for combating HIV infection
H.T. Denver, C.M. de Noronha, D.-A. Borca-Tasciuc, Rensselaer Polytechnic Institute, US
10:50 A broad-spectrum viricide and its application as a novel human anti-viral therapeutic system
E. Seymour, A. Diwan, V. Boniuk, R. Barton, NanoViricides, Inc., US
11:10 Gene Delivery and Transfection Studies with Lipopolyplexes in Human Endothelial and Smooth Muscle Cells
L. Brito, S. Little, R. Langer, M. Amiji, Northeastern University, US
11:30 A Micro-Implant based on MEMS (Micro-Electro-Mechanical-Sysems) Technology for Treatment of Hemorrhagic Shock in Ambulatory Settings
N.M. Elman, H-L. Ho Duc, M.J. Cima, Massachusttes Institute of Technology, US
11:50 Development of Peptide Nucleic Acid Assemblies for Application in Drug Delivery and Molecular Sensing
F.N. Butler, O. Elibol, B.D. Hines, B. Reddy Jr., R. Bashir, D.E. Bergstrom, Purdue University, US
Back to Top
1:30 Lab on Chip - 2Room 308
 Session chair: Hang Lu, Georgia Institute of Technology, US
1:30 One-step Target Protein detection from Whole Blood in a Lab-on-a-Disc
B.S. Lee, J.G. Lee, J.N. Lee, J.M. Park, Y.K. Cho, S. Kim, C. Ko, Samsung Advanced Institute of Technology, KR
1:50 Using Microfluidics for Metabolic Monitoring of Single Embryo Cultures
T. Thorsen, J.-P. Urbanski, M.T. Johnson, D.D. Craig, D.L. Potter, D.K. Gardner, Massachusetts Institute of Technology, US
2:10 DNA Extraction Chip Using Key-type Planar Electrodes
S.M. Azimi, W. Balachandran, J. Ahern, P. Slijepcevic, C. Newton, Brunel University, UK
2:30 Amperometric glucose sensor for real time extracellular glucose monitoring in microfluidic device
I.A. Ges, F.J. Baudenbacher, Vanderbilt University, US

Special Symposium

Nanotechnology has the potential to have a revolutionary impact on modern medicine, not only through the development of novel diagnosis and imaging methods, but also through targeted therapies. It is universally accepted that early detection of disease is essential even before anatomic anomalies are visible. A major challenge in diagnostics in the 21st century is to be able to determine the exact relationship between biomarkers and the clinical pathology, as well as, to be able to non-invasively detect diseases at an early stage for maximum therapeutic benefit.

Imaging, a critically important tool in life sciences is benefiting from the advances in the development of nano scale particles and systems that improve and extend the capabilities of imaging techniques. These include novel contrast agents, quantum dot markers, engineered ligands, and smart particles that enable imaging down to the cellular, and molecular scales with higher selectivity and signals that previously possible.

In future nano medical therapy, targeting and localized delivery are the key challenges. To wage an effective war against disease, we have to have the ability to selectively target the diseased cells, while saving the normal tissue from excessive burdens of drug toxicity. However, because many drugs are systemic in the delivery, the distribution of drugs in healthy organs or tissues is especially undesirable due to the potential for side effects. Consequently, systemic application of these drugs often causes severe side effects in other tissues (e.g. cardiomyopathy, neurotoxicity), which greatly limits the maximal allowable dose of the drug.

This symposium will address the potential ways in which nanotechnology can address these challenges. Distinguished speakers will summarize the current state of the art and future barriers. Contributions are also solicited in the following topics.

Topics & Application Areas

Online abstract submissions are now being accepted. Proposed topics include, but are not be limited to:

  • Medical Imaging, Agents, Markers, Particles
  • Molecular Imaging
  • Cell Signaling
  • Cell Surface Interactions
  • Cellular & Nanostructure Material Interactions
  • Molecular machines, receptors, pores & channels
  • Novel Drug Delivery
  • Novel Therapies
  • Other

Journal Submissions

Nanomedicine: Nanotechnology, Biology and Medicine (Nanomedicine)

Nanomedicine: Nanotechnology, Biology and Medicine (Nanomedicine)

Nanomedicine: Nanotechnology, Biology and Medicine (Nanomedicine) is a newly established, international, peer-reviewed journal published quarterly. Nanomedicine publishes basic, clinical, and engineering research in the innovative field of nanomedicine. Article categories include basic nanomedicine, diagnostic nanomedicine, experimental nanomedicine, clinical nanomedicine, and engineering nanomedicine, pharmacological nanomedicine.

For consideration into the Nanomedicine: Nanotechnology, Biology and Medicine journal please select the “Submit to Nanomedicine: Nanotechnology, Biology and Medicine” button during the on-line submission procedure. You may only select a single journal during the submission process.

Journal of Nanoparticle Research

Journal of Nanoparticle Research

Selected Nanotech Proceedings papers will be reviewed and invited into a Special Issue of Journal of Nanoparticle Research. The journal disseminates knowledge of the physical, chemical and biological phenomena and processes in nanoscale structures.

For consideration into this Special Issue of Journal of Nanoparticle Research, please select the “Submit to Journal of Nanoparticle Research” button during the on-line submission procedure. You may only select a single journal during the submission process.

Symposium Coordinator

Matthew Laudon
Nano Science and Technology Institute